Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Stopped early · Phase 3

Conditions studied: Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Depression, Fatigue, Quality of Life

In brief

RATIONALE: Methylphenidate may decrease side effects of radiation therapy. It is not yet known if methylphenidate is effective in improving quality of life in patients with primary or metastatic brain tumors. PURPOSE: Randomized phase III trial to determine the effectiveness of methylphenidate in improving quality of life in patients who have brain tumors and are undergoing radiation therapy.

Key facts

Study ID

NCT00031798

Run by

Wake Forest University Health Sciences

Starts

2002-04-01

Expected to finish

2006-05-01

Last updated by the study team

2021-09-09

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• CCOP - Western Regional, Arizona — Phoenix, Arizona, United States
• CCOP - Central Illinois — Decatur, Illinois, United States
• MBCCOP - LSU Health Sciences Center — New Orleans, Louisiana, United States
• CCOP - Southeast Cancer Control Consortium — Goldsboro, North Carolina, United States
• Comprehensive Cancer Center at Wake Forest University — Winston-Salem, North Carolina, United States
• CCOP - Columbus — Columbus, Ohio, United States
• CCOP - Upstate Carolina — Spartanburg, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.